CC Stock Price, Chemours Co-The Quote, Chart

Market Summary

USD26.47+0.10

Market Closed

0.38%

CC Stock Price

View Fullscreen

CC RSI Chart

CC Valuation

Market Cap

3.9B

Price/Earnings (Trailing)

-16.56

Price/Sales (Trailing)

0.65

EV/EBITDA

34.05

Price/Free Cashflow

21.1

CC Price/Sales (Trailing)

CC Profitability

EBT Margin

-5.11%

Return on Equity

-30.99%

Return on Assets

-2.78%

Free Cashflow Yield

4.74%

CC Fundamentals

CC Revenue

Revenue (TTM)

6.0B

Rev. Growth (Yr)

1.72%

Rev. Growth (Qtr)

-8.47%

CC Earnings

Earnings (TTM)

-229.0M

Earnings Growth (Yr)

81.44%

Earnings Growth (Qtr)

-250%

Breaking Down CC Revenue

Last 7 days

-4.1%

Last 30 days

-5.1%

Last 90 days

-10.1%

Trailing 12 Months

-10.7%

How does CC drawdown profile look like?

CC Financial Health

Current Ratio

1.54

Debt/Equity

5.34

Debt/Cashflow

0.14

CC Investor Care

Dividend Yield

3.79%

Dividend/Share (TTM)

1

Buy Backs (1Y)

0.21%

Diluted EPS (TTM)

-1.6

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	6.6B	6.3B	6.0B	6.0B
2022	6.7B	6.9B	7.0B	6.8B
2021	5.1B	5.7B	6.1B	6.3B
2020	5.5B	5.1B	5.0B	5.0B
2019	6.3B	5.9B	5.6B	5.5B
2018	6.5B	6.7B	6.7B	6.6B
2017	5.5B	5.7B	5.9B	6.2B
2016	5.7B	5.5B	5.4B	5.4B
2015	6.2B	6.1B	5.9B	5.7B
2014	6.8B	6.6B	6.5B	6.4B
2013	0	0	0	6.9B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Chemours Co-The

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 27, 2024	abbott matthew s	acquired	-	-	6,331	interim cfo
Mar 27, 2024	scarborough alvenia	sold (taxes)	-51,435	28.88	-1,781	svp corp communications & cbo
Mar 27, 2024	abbott matthew s	sold (taxes)	-58,886	28.88	-2,039	interim cfo
Mar 27, 2024	dignam denise	acquired	-	-	9,496	president & ceo
Mar 27, 2024	scarborough alvenia	acquired	-	-	5,276	svp corp communications & cbo
Mar 27, 2024	dignam denise	sold (taxes)	-88,315	28.88	-3,058	president & ceo
Mar 01, 2024	martinko joseph t.	sold (taxes)	-16,520	20.78	-795	president, thermal & specializ
Mar 01, 2024	dignam denise	sold (taxes)	-26,993	20.78	-1,299	interim ceo
Mar 01, 2024	familiar calderon gerardo	sold (taxes)	-15,522	20.78	-747	pres advanced performance mat
Mar 01, 2024	abbott matthew s	sold (taxes)	-91,743	20.78	-4,415	interim cfo

Which funds bought or sold CC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 17, 2024	JEPPSON WEALTH MANAGEMENT, LLC	sold off	-100	-275,943	-	-%
Apr 17, 2024	Coston, McIsaac & Partners	unchanged	-	-	1,000	-%
Apr 17, 2024	BARRETT & COMPANY, INC.	reduced	-22.22	-1,001	1,838	-%
Apr 17, 2024	NEW MEXICO EDUCATIONAL RETIREMENT BOARD	added	12.87	121,000	1,077,000	0.04%
Apr 17, 2024	Iron Horse Wealth Management, LLC	unchanged	-	-665	3,309	-%
Apr 17, 2024	Stephens Consulting, LLC	unchanged	-	-1,136	5,646	-%
Apr 17, 2024	PEOPLES FINANCIAL SERVICES CORP.	unchanged	-	-692	3,438	-%
Apr 16, 2024	COUNTRY TRUST BANK	added	12.04	-404	5,620	-%
Apr 16, 2024	Tanglewood Legacy Advisors, LLC	unchanged	-	-7,054	35,083	0.02%
Apr 16, 2024	Register Financial Advisors LLC	new	-	1,050	1,050	-%

Are Funds Buying or Selling CC?

Are funds buying CC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own CC

No. of Funds

Unveiling Chemours Co-The's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	10.80%	16,028,054	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 24, 2024	blackrock inc.	11.1%	16,512,174	SC 13G/A
Apr 10, 2023	fmr llc	-	0	SC 13G/A
Feb 14, 2023	sessa capital (master), l.p.	0.36%	547,057	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	12.20%	18,416,153	SC 13G/A
Jan 26, 2023	blackrock inc.	12.3%	18,516,903	SC 13G/A
Jan 20, 2023	blackrock inc.	12.3%	18,516,903	SC 13G/A
Apr 08, 2022	blackrock inc.	11.3%	18,075,740	SC 13G/A

Recent SEC filings of Chemours Co-The

View All Filings

Date Filed	Form Type	Document
Apr 11, 2024	ARS	ARS
Apr 11, 2024	DEF 14A	DEF 14A
Apr 11, 2024	DEFA14A	DEFA14A
Apr 01, 2024	3/A	Insider Trading
Mar 29, 2024	8-K	Current Report
Mar 29, 2024	4	Insider Trading
Mar 29, 2024	4	Insider Trading
Mar 29, 2024	4	Insider Trading
Mar 29, 2024	3	Insider Trading
Mar 28, 2024	8-K	Current Report

Peers (Alternatives to Chemours Co-The)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
APD	51.0B	12.4B	-6.76%	-20.43%	21.8	4.1	-3.54%	3.06%
DOW	40.1B	44.6B	0.14%	0.07%	60.75	0.9	-21.58%	-85.78%
CE	16.8B	10.9B	-4.87%	41.04%	8.58	1.54	13.10%	3.48%
AVTR	16.5B	7.0B	-4.28%	19.28%	51.5	2.37	-7.26%	-53.23%
ALB	13.4B	9.6B	-8.16%	-44.26%	8.54	1.4	31.38%	-41.50%
EMN	11.3B	9.2B	3.95%	16.30%	12.59	1.22	-12.95%	12.74%
MID-CAP
CBT	5.1B	3.9B	4.25%	22.55%	11.45	1.3	-9.12%	26.64%
BCPC	4.6B	922.4M	-7.81%	12.79%	42.75	5.03	-2.11%	3.01%
AVNT	3.8B	3.1B	4.72%	4.25%	50.51	1.22	-7.48%	-89.19%
ARCH	3.0B	3.1B	2.16%	22.91%	6.53	0.96	-15.54%	-65.21%
SMALL-CAP
CCF	1.2B	404.0M	0.11%	32.60%	36.59	3	24.06%	-25.72%
ASIX	712.6M	1.5B	4.14%	-32.17%	13.05	0.46	-21.18%	-60.55%
CMT	172.4M	357.7M	5.30%	-1.19%	8.48	0.48	-5.20%	66.55%
AREC	108.8M	16.7M	-23.60%	5.43%	9.82	6.5	-57.58%	866.09%
AMRS	3.7M	-	-80.00%	-99.58%	-0.01	0.01	-	-

Chemours Co-The News

Latest updates

Chemours Co-The Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-8.5%	1,361	1,487	1,643	1,536	1,338	1,777	1,915	1,764	1,575	1,680	1,655	1,436	1,338	1,233	1,093	1,305	1,353	1,390	1,408	1,376	1,464
Gross Profit	-6.6%	255	273	410	368	202	432	497	486	393	427	264	297	313	257	199	298	150	294	323	296	400
Operating Expenses	-18.3%	261	319	806	166	211	171	280	182	190	154	204	158	250	143	147	160	183	184	162	186	229
S&GA Expenses	34.8%	223	165	779	124	175	140	254	141	158	124	172	139	180	112	110	125	126	130	136	156	191
R&D Expenses	-7.1%	26.00	28.00	28.00	26.00	31.00	32.00	25.00	30.00	29.00	27.00	27.00	24.00	27.00	22.00	20.00	24.00	19.00	20.00	19.00	22.00	22.00
EBITDA Margin	10.9%	0.03*	0.03*	0.07*	0.17*	0.18*	0.22*	0.22*	0.20*	0.19*	0.15*	0.13*	0.14*	-	-	-	-	-	-	-	-	-
Interest Expenses	14.5%	63.00	55.00	48.00	42.00	41.00	41.00	40.00	41.00	44.00	45.00	47.00	49.00	50.00	53.00	53.00	54.00	52.00	53.00	52.00	51.00	343
Income Taxes	-5400.0%	-53.00	1.00	-57.00	28.00	28.00	59.00	30.00	46.00	69.00	17.00	-22.00	5.00	4.00	-16.00	-4.00	-23.00	-137	15.00	37.00	13.00	40.00
Earnings Before Taxes	-646.2%	-71.00	13.00	-433	173	-69.00	299	231	280	301	231	44.00	101	23.00	60.00	20.00	77.00	-454	91.00	133	107	182
EBT Margin	-0.3%	-0.05*	-0.05*	0.00*	0.10*	0.11*	0.16*	0.15*	0.13*	0.11*	0.07*	0.04*	0.04*	-	-	-	-	-	-	-	-	-
Net Income	-250.0%	-18.00	12.00	-376	145	-97.00	240	201	234	233	214	66.00	96.00	19.00	76.00	24.00	100	-317	76.00	96.00	94.00	142
Net Income Margin	25.9%	-0.04*	-0.05*	-0.01*	0.07*	0.09*	0.13*	0.13*	0.11*	0.10*	0.06*	0.05*	0.04*	-	-	-	-	-	-	-	-	-
Free Cashflow	693.2%	349	44.00	3.00	-210	93.00	229	229	-104	131	244	189	-21.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	3.8%	8,251	7,948	7,660	7,624	7,640	7,745	7,730	7,524	7,550	7,530	7,479	7,170	7,082	6,948	7,034	6,948	7,258	7,456	7,433	7,325	7,362
Current Assets	4.1%	3,835	3,683	3,374	3,202	3,214	3,543	3,606	3,393	3,345	3,371	3,047	2,786	2,633	2,605	2,717	2,591	2,777	2,827	2,832	2,847	3,293
Cash Equivalents	41.2%	1,203	852	738	816	1,102	1,368	1,348	1,245	1,451	1,131	1,139	1,008	1,105	956	1,031	714	943	694	630	697	1,201
Inventory	2.9%	1,352	1,314	1,446	1,486	1,404	1,321	1,219	1,166	1,099	1,016	1,046	988	939	993	1,074	1,114	1,079	1,223	1,250	1,218	1,147
Net PPE	3.1%	3,216	3,119	3,190	3,180	3,171	3,071	3,111	3,131	3,154	3,127	3,448	3,432	3,474	3,418	3,423	3,444	3,559	3,520	3,491	3,379	3,291
Goodwill	0%	102	102	102	102	102	102	102	102	102	102	153	152	153	-	-	-	153	-	-	-	4.00
Liabilities	4.3%	7,512	7,199	6,850	6,396	6,533	6,460	6,515	6,357	6,468	6,531	6,579	6,318	6,267	6,214	6,375	6,287	6,563	6,613	6,604	6,509	6,342
Current Liabilities	-15.0%	2,486	2,925	2,190	1,745	1,891	1,951	1,886	1,775	1,858	1,779	1,674	1,501	1,442	1,308	1,156	1,343	1,541	1,643	1,448	1,572	1,709
Long Term Debt	1.1%	3,987	3,944	3,604	3,599	3,590	3,510	3,656	3,692	3,724	3,829	3,964	3,970	4,005	4,063	4,327	4,012	4,026	4,007	4,190	3,965	3,959
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	18.00	13.00	13.00
LT Debt, Non Current	1.1%	3,987	3,944	3,604	3,599	3,590	3,510	3,656	3,692	3,724	3,829	3,964	3,970	4,005	4,063	4,327	4,012	4,026	4,007	4,190	3,965	3,959
Shareholder's Equity	-1.6%	737	749	810	1,228	1,107	1,285	1,215	1,167	1,082	999	900	852	815	734	659	661	695	843	829	816	1,020
Retained Earnings	-3.0%	1,782	1,837	1,864	2,278	2,170	2,304	2,102	1,940	1,746	1,554	1,381	1,357	1,303	1,325	1,290	1,308	1,249	1,606	1,571	1,517	1,466
Additional Paid-In Capital	0.3%	1,033	1,030	1,014	1,004	1,016	1,015	1,005	956	944	926	920	907	890	879	872	870	859	857	853	845	860
Accumulated Depreciation	1.2%	6,196	6,124	6,358	6,319	6,216	6,115	6,153	6,123	6,078	6,080	6,220	6,121	6,108	5,973	5,873	5,770	5,854	5,754	5,768	5,710	5,701
Shares Outstanding	0.2%	149	148	148	149	149	153	156	157	161	164	165	165	-	-	-	-	-	-	-	-	-
Minority Interest	0%	2.00	2.00	2.00	1.00	-	1.00	1.00	1.00	1.00	1.00	2.00	2.00	2.00	2.00	2.00	6.00	6.00	6.00	6.00	6.00	6.00
Float	-	-	-	5,500	-	-	-	5,000	-	-	-	5,700	-	-	-	2,500	-	-	-	3,900	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	267.9%	482,000	131,000	67,000	-124,000	161,000	301,000	291,000	2,000	208,000	311,000	256,000	39,000	353,000	299,000	111,000	44,000	400,000	288,000	6,000	-44,000	259,000
Share Based Compensation	-16.7%	5,000	6,000	3,000	4,000	3,000	7,000	7,000	10,000	10,000	4,000	8,000	12,000	4,000	3,000	1,000	8,000	1,000	4,000	6,000	8,000	4,000
Cashflow From Investing	-324.1%	-130,000	58,000	-60,000	-97,000	-65,000	-74,000	-35,000	-110,000	422,000	-68,000	-57,000	-77,000	-34,000	-37,000	-51,000	-112,000	-96,000	-131,000	-122,000	-134,000	-160,000
Cashflow From Financing	-101.5%	-5,000	324,000	-79,000	-68,000	-191,000	-175,000	-131,000	-189,000	-195,000	-241,000	-76,000	-42,000	-187,000	-354,000	247,000	-155,000	-59,000	-77,000	41,000	-324,000	-170,000
Dividend Payments	0%	37,000	37,000	38,000	37,000	37,000	39,000	38,000	40,000	41,000	41,000	41,000	41,000	41,000	41,000	41,000	41,000	40,000	41,000	41,000	42,000	42,000
Buy Backs	-100.0%	-	18,000	37,000	14,000	144,000	79,000	128,000	144,000	93,000	67,000	13,000	-	-	-	-	-	-	-	67,000	255,000	124,000

CC Income Statement

2023-12-31

Consolidated Statements of Operations $ in Millions	12 Months Ended
Consolidated Statements of Operations $ in Millions	Dec. 31, 2023 USD ($) $ / shares
Income Statement [Abstract]
Net sales	$ 6,027
Cost of goods sold	4,721
Gross profit	1,306
Selling, general, and administrative expense	1,290
Research and development expense	108
Restructuring, asset-related, and other charges	153
Total other operating expenses	1,551
Equity in earnings of affiliates	45
Interest expense, net	(208)
(Loss) gain on extinguishment of debt	(1)
Other income , net	91
(Loss) income before income taxes	(318)
(Benefit from) provision for income taxes	(81)
Net (loss) income	(237)
Less: Net income attributable to non-controlling interests	1
Net (loss) income attributable to Chemours	$ (238)
Per share data
Basic (loss) earnings per share of common stock \| $ / shares	$ (1.60)
Diluted (loss) earnings per share of common stock \| $ / shares	$ (1.60)

CC Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,203	$ 1,102
Restricted cash and restricted cash equivalents	604
Accounts and notes receivable, net	610	626
Inventories	1,352	1,404
Prepaid expenses and other	66	82
Total current assets	3,835	3,214
Property, plant, and equipment	9,412	9,387
Less: Accumulated depreciation	(6,196)	(6,216)
Property, plant, and equipment, net	3,216	3,171
Operating lease right-of-use assets	260	240
Goodwill	102	102
Other intangible assets, net	3	13
Investments in affiliates	158	175
Restricted cash and restricted cash equivalents		202
Other assets	677	523
Total assets	8,251	7,640
Current liabilities:
Accounts payable	1,159	1,233
Compensation and other employee-related cost	89	121
Short-term and current maturities of long-term debt	51	43
Current environmental remediation	129	194
Other accrued liabilities	1,058	300
Total current liabilities	2,486	1,891
Long-term debt, net	3,987	3,590
Operating lease liabilities	206	198
Long-term environmental remediation	461	474
Deferred income taxes	44	61
Other liabilities	328	319
Total liabilities	7,512	6,533
Commitments and contingent liabilities
Equity
Common stock (par value $0.01 per share; 810,000,000 shares authorized; 197,519,784 shares issued and 148,587,397 shares outstanding at December 31, 2023; 195,375,810 shares issued and 148,504,030 shares outstanding at December 31, 2022)	2	2
Treasury stock, at cost (48,932,387 shares at December 31, 2023; 46,871,780 shares at December 31, 2022)	(1,806)	(1,738)
Additional paid-in capital	1,033	1,016
Retained earnings	1,782	2,170
Accumulated other comprehensive loss	(274)	(343)
Total Chemours stockholders’ equity	737	1,107
Non-controlling interests	2
Total equity	739	1,107
Total liabilities and equity	$ 8,251	$ 7,640

About Chemours Co-The

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

CEO	Mr. Mark E. Newman
WEBSITE	chemours.com
INDUSTRY	Chemicals
EMPLOYEES	6600

Chemours Co-The Frequently Asked Questions

What is the ticker symbol for Chemours Co-The? What does CC stand for in stocks?

CC is the stock ticker symbol of Chemours Co-The. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Chemours Co-The (CC)?

As of Wed Apr 17 2024, market cap of Chemours Co-The is 3.92 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CC stock?

You can check CC's fair value in chart for subscribers.

What is the fair value of CC stock?

You can check CC's fair value in chart for subscribers. The fair value of Chemours Co-The is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Chemours Co-The is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Chemours Co-The a good stock to buy?

The fair value guage provides a quick view whether CC is over valued or under valued. Whether Chemours Co-The is cheap or expensive depends on the assumptions which impact Chemours Co-The's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CC.

What is Chemours Co-The's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 17 2024, CC's PE ratio (Price to Earnings) is -16.56 and Price to Sales (PS) ratio is 0.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CC PE ratio will change depending on the future growth rate expectations of investors.